Bortezomib
CAS 179324-69-7
In Stock
Bortezomib
Cat. No. ANT-BTZ-00CAS 179324-69-7In Stock
Technical Data
Cat. No.ANT-BTZ-00
CAS179324-69-7
Mol. FormulaC19H25BN4O4
Mol. Weight384.24 g/mol
IUPAC[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
SMILESB([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
InChIInChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
InChI KeyGXJABQQUPOEUTA-RDJZCZTQSA-N
PurityNA
Description
Overview
Boltezomib is an anti-cancer drug used to treat multiple myeloma and mantle cell lymphoma. This includes those who have not been treated before and multiple myeloma. It is commonly used in combination with other drugs. It is given by injection
Anant Labs manufacture and furnish high quality Bortezomib impurities for global markets. Our Bortezomib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acidBortezomib179324-69-7VelcadePS-341LDP-341NSC-681239LDP 341Bortezomib accord69G8BD63PP
